Testosterone propionate is a slower-releasing anabolic steroid with a short half-life. It is a synthetic androstane steroid derivative of testosterone in the form of 17β propionate ester of testosterone. Testosterone propionate was developed initially by Watson labs, and FDA approved on February 5, 1974. Currently, this drug has been discontinued in humans, but the vet application is still available as an OTC. It is grouped under the following drug class(es): Androgens and Hormones. Its therapeutic use is listed as sexual dysfunction agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Androlon, Androteston, Aquaviron, Hormoteston, Enarmon and Bio-testiculina. It is listed as a controlled drug substance (Schedule III). Its PubChem CID is 5995.
Testosterone propionate
| CAS No | 57-85-2 |
|---|---|
| Molecular Formula | C22H32O3 |
| Molecular Weight | 344.5 g/mol |
| Synonyms | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Testosterone propionate is a slower-releasing anabolic steroid with a short half-life. It is a synthetic androstane steroid derivative of testosterone in the form of 17β propionate ester of testosterone.
The listed CAS number is 57-85-2.
The listed molecular formula is C22H32O3.
The listed molecular weight is 344.5 g/mol.
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate.
The source lists Androlon, Androteston, Aquaviron, Hormoteston, Enarmon and Bio-testiculina.